Although pulmonary hypertension (PH) is a common complication of sickle cell disease (SCD) associated with high mortality, there exist few data characterizing hemodynamics and cardiopulmonary function in this population. To characterize hemodynamics and cardiopulmonary function in patients with SCD with and without PH. Patients with SCD with PH (n = 26) were compared with control subjects with SCD but without PH (n = 17), matched for age, hemoglobin levels, and fetal hemoglobin levels. Upon catheterization, 54% of the patients with PH had pulmonary arterial hypertension, and 46% had pulmonary venous hypertension. When compared with control subjects, patients with PH exhibited lower six-minute-walk distance (435 +/- 31 vs. 320 +/- 20 m, p = 0.002) and oxygen consumption (50 +/- 3% vs. 41 +/- 2% of predicted, p = 0.02), and also had mild restrictive lung disease and more perfusion abnormalities on radionuclide lung scans. The six-minute-walk distance in this population inversely correlated with tricuspid regurgitant jet velocity (r = -0.55, p < 0.001), and mean pulmonary artery pressure (r = -0.57, p < 0.001), and directly correlated with maximal oxygen consumption (r = 0.49, p = 0.004), even after adjustment for hemoglobin, supp...Continue Reading
Mitral valve replacement with ball and tilting disc valve prosthesis. A clinical and haemodynamic study
Systemic surgical shunts and splenomegaly as causes of haemolysis in portal hypertension in mansonic schistosomiasis. Evaluation through serum levels of haptoglobin, hemopexin and bilirubins
Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound
American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update
Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension
Hemolytic characteristics of a pivot bearing supported Gyro centrifugal pump (C1E3) simulating various clinical applications
A clinical evaluation of platelet function, haemolysis and oxygen transfer during cardiopulmonary bypass comparing the Quantum HF-6700 to the HF-5700 hollow fibre membrane oxygenator
Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research
Haemolysis during cardiopulmonary bypass: how to reduce the free haemoglobin by managing the suctioned blood separately
Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies
Impaired oxygenation and increased hemolysis after cardiopulmonary bypass in patients with glucose-6-phosphate dehydrogenase deficiency
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease
Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease
Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension
Mitral valve repair versus replacement for moderate-to-severe mitral regurgitation in patients undergoing concomitant aortic valve replacement
Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment
The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease
Uric Acid as a potential biomarker of pulmonary arterial hypertension in patients with sickle cell disease
Misclassification of pulmonary hypertension in adults with sickle hemoglobinopathies using Doppler echocardiography
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom
Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease
Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report
Hematological and hemorheological determinants of the six-minute walk test performance in children with sickle cell anemia
The PhysioFlow thoracic impedancemeter is not valid for the measurements of cardiac hemodynamic parameters in chronic anemic patients
Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia
Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom
Segmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease
Clinical and electrocardiographic evaluation of sickle-cell anaemia patients with pulmonary hypertension
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia
The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients
Predictive models of six-minute walking distance in adults with sickle cell anemia: Implications for rehabilitation
Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia
Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease
Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension
Functional capacity in children and young adults with sickle cell disease undergoing evaluation for cardiopulmonary disease
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions
Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy
Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease
Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression
Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease
The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom
Pulmonary artery occlusion pressure may overdiagnose pulmonary artery hypertension in sickle cell disease
Mild haemorheological changes induced by a moderate endurance exercise in patients with sickle cell anaemia
Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: relation to pulmonary hypertension and aortic wall stiffness
NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease
Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine
Exercise tolerance, lung function abnormalities, anemia, and cardiothoracic ratio in sickle cell patients
Letter in response to: "Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity"
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
Evaluation of functional capacity for exercise in children and adolescents with sickle-cell disease through the six-minute walk test
Raised erythrocyte creatine in patients with pulmonary arterial hypertension--evidence for subclinical hemolysis
Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension.
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity
Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension
Successful pulmonary thromboendarterectomy in a patient with sickle cell disease and associated resolution of a leg ulcer
Effects of living at moderate altitude on pulmonary vascular function and exercise capacity in mice with sickle cell anaemia
Exercise capacity and clinical outcomes in adults followed in the Cooperative Study of Sickle Cell Disease (CSSCD)
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association
Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease
A novel expression of exercise induced pulmonary hypertension in human immunodeficiency virus patients: a pilot study
Splenectomy is not associated with a higher tricuspid regurgitant jet velocity in people with sickle cell anemia
Potential Contribution of Pulmonary Thromboembolic Disease in Pulmonary Hypertension in Sickle Cell Disease.
Muscle structural, energetic and functional benefits of endurance exercise training in sickle cell disease
N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension
Prevalence, risk factors and mortality of pulmonary hypertension defined by right heart catheterization in patients with sickle cell disease
Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention
Pulmonary function in children and adolescents with sickle cell disease: have we paid proper attention to this problem?
Relationship between ventilation heterogeneity and exercise intolerance in adults with sickle cell anemia
The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis
Reduced fitness and abnormal cardiopulmonary responses to maximal exercise testing in children and young adults with sickle cell anemia
Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice
One-Fifth of Children with Sickle Cell Anemia Show Exercise-Induced Hemoglobin Desaturation: Rate of Perceived Exertion and Role of Blood Rheology
Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension
Focused Update on Pulmonary Hypertension in Children-Selected Topics of Interest for the Adult Cardiologist.
Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.
American Thoracic Association Journals
Discover the latest respiratory research published by the journals from the American Thoracic Society.
Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.
Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.
Blood And Marrow Transplantation
The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.